Company profile for Transgene

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Transgene is a biotechnology company that designs and develops innovative immunotherapies, in clinical and preclinical settings. Whether therapeutic vaccines or oncolytic viruses, Transgene pushes the boundaries of innovation every day to design the treatments doctors need to better care for their patients. Our approach exploits the mechanisms of the immune response to enable the patient to defend himself against the disease. ...
Transgene is a biotechnology company that designs and develops innovative immunotherapies, in clinical and preclinical settings. Whether therapeutic vaccines or oncolytic viruses, Transgene pushes the boundaries of innovation every day to design the treatments doctors need to better care for their patients. Our approach exploits the mechanisms of the immune response to enable the patient to defend himself against the disease. At Transgene, we integrate genetic sequences (or transgenes) into viral vectors to create a weapon capable of destroying abnormal cells.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
France
Address
Address
400 Boulevard Gonthier d'Andernach Parc d'Innovation - CS80166 67405 Illkirch-...
Telephone
Telephone
+ 33 (0) 3 88 27 91 00
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/07/3183539/0/en/GenVivo-to-Present-Phase-1-Trial-Results-for-GEN2-A-Personalizing-Systemic-Cancer-Immunotherapy-at-the-2025-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting.html

GLOBENEWSWIRE
07 Nov 2025

https://www.pharmiweb.com/press-release/2025-11-06/transgene-to-showcase-potential-of-proprietary-vacdesignr-computational-tool-to-optimize-individualized-therapeutic-cancer-vaccines

PHARMIWEB
06 Nov 2025

https://www.accessnewswire.com/newsroom/en/biotechnology/transgene-and-bioinvents-armed-oncolytic-virus-bt-001-shows-positive-local-abscopal-a-1089300

ACCESSWIRE
20 Oct 2025

https://www.accessnewswire.com/newsroom/en/biotechnology/transgene-and-bioinvent-to-present-translational-data-and-updated-clinical-results-on-1086026

ACCESSWIRE
13 Oct 2025

https://www.pharmiweb.com/press-release/2025-10-06/transgene-to-present-new-immunological-data-from-phase-i-trial-of-individualized-therapeutic-cancer-vaccine-tg4050-at-sitc-2025

PHARMAWEB
06 Oct 2025

https://www.accessnewswire.com/newsroom/en/biotechnology/transgene-and-bioinvent-to-present-updated-data-on-armed-oncolytic-virus-bt-001-at-es-1053412

ACCESSWIRE
28 Jul 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty